LATEST
外 Waitan Ludi Policy Terminal China industrial-policy monitor · updated 2026-10-25

Programme evidence / 深圳

High-end medical-device investment support — Shenzhen

Device projects within strategic-emerging-industry funding; exclude drug-only projects from recipient observations.

1Reviewed documents
0Reviewed recipient observations
0Recipient observations to review

Window: 2020–2026; earlier legal bases can be included as context. Reviewed source labels confirm programme association and document stage. They do not confirm current legal force or payment. Allocation, eligibility and payment are separate meanings; no cross-instrument monetary total is calculated.

Policy basis · Reviewed evidenceImplementing rules · Searched; unresolvedApplications · Searched; unresolvedProposed recipients · Searched; unresolvedFinal allocations · Searched; unresolvedSettlement / recovery · Searched; unresolvedEvaluation / renewal · Searched; unresolved
Coverage by explicitly assigned round year

Blank years are not evidence that a programme did not operate. Cross-year rules and notices without an established round year appear below.

RoundPolicy basisImplementing rulesApplicationsProposed recipientsFinal allocationsSettlement / recoveryEvaluation / renewal
2026———————
2025———————
2024———————
2023———————
2022———————
2021———————
2020———————

Eligibility and support terms

Source-specific rules; historical versions and exceptions may differ. These are not an automated eligibility decision.

No terms reviewed yet.

Policy basis

深圳市发展和改革委员会 深圳市卫生健康委员会 深圳市市场监督管理局 深圳市医疗保障局关于印发《深圳市全链条支持医药和医疗器械发展若干措施》的通知
2025-04-02 · 深圳市发展和改革委员会 深圳市卫生健康委员会 深圳市市场监督管理局 深圳市医疗保障局 · cross-year / round not established · Municipal umbrella framework; not an award decision · Reviewed source
各有关单位: 《深圳市全链条支持医药和医疗器械发展若干措施》已经市政府同意,现予以印发,请遵照执行。 特此通知。 深圳市发展和改革委员会深圳市卫生健康委员会 深圳市市场监督管理局深圳市医疗保障局 2025年4月2日 深圳市全链条支持医药和医疗器械发展若干措施 为深入贯彻落实党的二十大和二十届二中、三中全会精神,以及国家、省关于发展医药和医疗器械产业的一系列决策部署,充分发挥深圳科技创新、先进制造、深港合作等优势,大力发展医药和医疗器械研发经济,全链条支持医药和医疗器械产业快速发展做大做强,将深圳建设成为国内领先、国际一流的医药和医疗器械产业集聚发展高地,制定以下措施。 一、全面激发创新策源活力 (一)聚力提高基础研究支持力度。推进全新机制基础研究机构建设,加大“深医专项”资金投入,围绕恶性肿瘤、心脑血管疾病、代谢性疾病、风湿免疫疾病等,支持新靶点、新机制、新结构等创新药基础理论研究,集中力量突破医药科技底层技术,建立专家实名推荐的非共识项目筛选机制。发挥重大科技基础设施、国家重点实验室、国家工程研究中心、国家临床医学研究中心等重大科研平台作用,集聚一批全球顶尖战略科学家、一流科技领军人才和创新团队、青年科技人才,加速培育颠覆性创新和重大原始创新研究成果。[责任单位:市发展改革委(市药械办)、市科技创新局、深圳医学科学院] (二)强化共性关键核心技术攻关。通过“揭榜挂帅”等遴选机制布局技术攻关项目,攻克一批药物筛选技术、载体构建技术、偶联药物技术、细胞规模化培养技术、中药复方制剂技

Reviewed programme association and document stage; not a legal-force or payment verification.

Original source ↗

Implementing rules

No evidence linked for this stage. See the search audit below; absence has not been established.

Applications

No evidence linked for this stage. See the search audit below; absence has not been established.

Proposed recipients

No evidence linked for this stage. See the search audit below; absence has not been established.

Final allocations

No evidence linked for this stage. See the search audit below; absence has not been established.

Settlement / recovery

No evidence linked for this stage. See the search audit below; absence has not been established.

Evaluation / renewal

No evidence linked for this stage. See the search audit below; absence has not been established.

Recipients and projects

Amounts retain their source meaning and unit. Proposed support and allocations are not confirmed payments. Candidate rows require source review.

Download reviewed CSV Include candidates in CSV

Recipient / projectRound / supported periodAmountMeaningEvidence
No recipient observations linked yet.

Search audit

A completed search records an attempt, not proof of completeness or non-publication. Search results are discovery leads, not citations.

Citation-rooted topic view →